Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, ...

A major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, the FDA found in a ...

The FDA today posted a warning letter sent to LeMaitre (LMAT), dated August 11, following an inspection of the company’s North Brunswick, New ...

FDA Considers Scaling Back Inspections, Raising Questions About Food Safety A federal pullback could shift oversight responsibilities to the states, with consumer groups expressing concern that ...

An official in the U.S. state of Louisiana has renewed his calls for there to be a national inspection fee on imported ...

Rogers led inspection efforts during the 2022 infant formula crisis, when the FDA was criticized for its slow response to problems at an infant formula plant linked to a deadly recall.

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7 ...